Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Detection and Identification of Bioanalytes with High Resolution LSPR Spectroscopy and MALDI Mass Spectrometry.

Literature DB >> 20161175

Detection and Identification of Bioanalytes with High Resolution LSPR Spectroscopy and MALDI Mass Spectrometry.

Jeffrey N Anker¹, W Paige Hall, Mary P Lambert, Pauline T Velasco, Milan Mrksich, William L Klein, Richard P Van Duyne.

Abstract

High resolution localized surface plasmon resonance (HR-LSPR) sensors were combined with matrix assisted laser desorption ionization mass spectrometry (MALDI-MS) for the first time. LSPR sensors provide real-time label-free detection of molecular adsorption. Subsequent MALDI-MS analysis enables identification of the adsorbed molecules. This synergistic LSPR-MS approach was applied to the detection and identification of amyloid beta oligomers which play an important role in the molecular pathogenesis of Alzheimer's Disease.

Entities: Chemical Disease Gene Species

Year: 2009 PMID： 20161175 PMCID： PMC2723955 DOI： 10.1021/jp900266k

Source DB: PubMed Journal: J Phys Chem C Nanomater Interfaces ISSN： 1932-7447 Impact factor: 4.126

23 in total

Review 1. Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.

Authors: William L Klein
Journal: Neurochem Int Date: 2002-11 Impact factor: 3.921

2. A comparative analysis of localized and propagating surface plasmon resonance sensors: the binding of concanavalin a to a monosaccharide functionalized self-assembled monolayer.

Authors: Chanda Ranjit Yonzon; Eunhee Jeoung; Shengli Zou; George C Schatz; Milan Mrksich; Richard P Van Duyne
Journal: J Am Chem Soc Date: 2004-10-06 Impact factor: 15.419

3. Gold-enhanced biomolecular surface imaging of cells and tissue by SIMS and MALDI mass spectrometry.

Authors: A F Maarten Altelaar; Ivo Klinkert; Kees Jalink; Robert P J de Lange; Roger A H Adan; Ron M A Heeren; Sander R Piersma
Journal: Anal Chem Date: 2006-02-01 Impact factor: 6.986

4. Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor.

Authors: Amanda J Haes; Lei Chang; William L Klein; Richard P Van Duyne
Journal: J Am Chem Soc Date: 2005-02-23 Impact factor: 15.419

5. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Authors: Hai-Wei Wang; Joseph F Pasternak; Helen Kuo; Helen Ristic; Mary P Lambert; Brett Chromy; Kirsten L Viola; William L Klein; W Blaine Stine; Grant A Krafft; Barbara L Trommer
Journal: Brain Res Date: 2002-01-11 Impact factor: 3.252

Review 6. Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules.

Authors: P Schuck
Journal: Annu Rev Biophys Biomol Struct Date: 1997

7. Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

Authors: Pascale N Lacor; Maria C Buniel; Lei Chang; Sara J Fernandez; Yuesong Gong; Kirsten L Viola; Mary P Lambert; Pauline T Velasco; Eileen H Bigio; Caleb E Finch; Grant A Krafft; William L Klein
Journal: J Neurosci Date: 2004-11-10 Impact factor: 6.167

8. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease.

Authors: Dimitra G Georganopoulou; Lei Chang; Jwa-Min Nam; C Shad Thaxton; Elliott J Mufson; William L Klein; Chad A Mirkin
Journal: Proc Natl Acad Sci U S A Date: 2005-02-04 Impact factor: 11.205

9. Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation.

Authors: Kevin J Barnham; Giuseppe D Ciccotosto; Anna K Tickler; Feda E Ali; Danielle G Smith; Nicholas A Williamson; Yuen-Han Lam; Darryl Carrington; Deborah Tew; Gulcan Kocak; Irene Volitakis; Frances Separovic; Colin J Barrow; John D Wade; Colin L Masters; Robert A Cherny; Cyril C Curtain; Ashley I Bush; Roberto Cappai
Journal: J Biol Chem Date: 2003-08-18 Impact factor: 5.157

10. Surface plasmon resonance analysis of Alzheimer's beta-amyloid aggregation on a solid surface: from monomers to fully-grown fibrils.

Authors: Jungki Ryu; Hyou-Arm Joung; Min-Gon Kim; Chan Beum Park
Journal: Anal Chem Date: 2008-02-28 Impact factor: 6.986

10 in total

1. Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal.

Authors: Jason Pitt; William Roth; Pascale Lacor; Amos B Smith; Matthew Blankenship; Pauline Velasco; Fernanda De Felice; Paul Breslin; William L Klein
Journal: Toxicol Appl Pharmacol Date: 2009-07-23 Impact factor: 4.219

2. Detection of Amyloid Beta (Aβ) Oligomeric Composition Using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry (MALDI MS).

Authors: Jasmine S-H Wang; Shawn N Whitehead; Ken K-C Yeung
Journal: J Am Soc Mass Spectrom Date: 2018-02-20 Impact factor: 3.109

Detection and Identification of Bioanalytes with High Resolution LSPR Spectroscopy and MALDI Mass Spectrometry.

Review 1. Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.

2. A comparative analysis of localized and propagating surface plasmon resonance sensors: the binding of concanavalin a to a monosaccharide functionalized self-assembled monolayer.

3. Gold-enhanced biomolecular surface imaging of cells and tissue by SIMS and MALDI mass spectrometry.

4. Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor.

5. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Review 6. Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules.

7. Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

8. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease.

9. Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation.

10. Surface plasmon resonance analysis of Alzheimer's beta-amyloid aggregation on a solid surface: from monomers to fully-grown fibrils.

1. Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal.

2. Detection of Amyloid Beta (Aβ) Oligomeric Composition Using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry (MALDI MS).

Review 3. Molecular plasmonics for biology and nanomedicine.

Review 4. Studying protein-protein affinity and immobilized ligand-protein affinity interactions using MS-based methods.

Review 5. Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.

6. Au nanostructure arrays for plasmonic applications: annealed island films versus nanoimprint lithography.

7. Self-Assembly and Anti-Amyloid Cytotoxicity Activity of Amyloid beta Peptide Derivatives.

Review 8. Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects.

9. Counting charges on membrane-bound peptides.

10. Plasmonic nanodisc arrays on calcinated titania for multimodal analysis of phosphorylated peptides.